LeafNLP Demos
Back to explore

Report #2875186

Received Nov 26, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
76 yrs
State
AZ
Recovered
Unknown
Vaccinated
Nov 21, 2025
Onset
Nov 21, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPABHEP A + HEP B (TWINRIX)GLAXOSMITHKLINE BIOLOGICALS2H7RF2—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

patient that received Twinrix 1st dose in 2015, and the 2nd dose 21-Nov-2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 76-year-old female patient who received HAB (Twinrix) (batch number H7RF2, expiry date 17-JAN-2026) for prophylaxis. Previously administered products included Twinrix (received 1st dose in 2015). On 21-NOV-2025, the patient received the 2nd dose of Twinrix. On 21-NOV-2025, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: patient that received Twinrix 1st dose in 2015, and the 2nd dose 21-Nov-2025). The outcome of the drug dose administration interval too long was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-NOV-2025 The vaccine administration facility was the same as primary reporter. :